In this special episode of The Points of CARE, recorded live during the American Diabetes Association's (ADA) 2026 Scientific Sessions in New Orleans, hosts Richard Beaser, MD and Jane Reusch, MD highlight a new symposium on the clinical, social, and economic costs of treating—or not treating—individuals with obesity.
This panel discussion is moderated by Louis J. Aronne, MD, Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College in New York, former president of the Obesity Society, and chair emeritus of the American Board of Obesity Medicine.
Presenters:
Timothy Dall, MS Managing Director for Life Sciences Consulting at GlobalData
Melanie R. Jay, MD, Professor of Medicine and Population Health at the New York University Grossman School of Medicine
Catherine Ferguson, MA, Vice President of Federal Advocacy for the ADA
Featured Articles:
The Cost of Inaction in Treating Obesity in the U.S. doi.org/10.2337/doci25-0011
Benefits and Costs of Treating Obesity Among Adults in Commercial Insurance Plans doi.org/10.2337/doci25-0006
Estimating the Health, Economic, and Social Benefits of Obesity Treatment Using Microsimulation Modeling doi.org/10.2337/doci25-0004
For more on the Cost of Obesity collection, visit diabetesjournals.org/collection/26413/Cost-of-Obesity
To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.